TCL Archive In Brief: All 77 New NCI Positions Go to Carcinogenesis Programs; “Not Wisest Way To Use Them” – Newell February 4, 1977
TCL Archive ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market September 26, 1997
TCL Archive NSABP Breast Cancer Prevention Trial Reports Final Results On Tamoxifen November 25, 2005